BR0214046A - Derivados de pirazol como substâncias psicofarmacêuticas - Google Patents
Derivados de pirazol como substâncias psicofarmacêuticasInfo
- Publication number
- BR0214046A BR0214046A BR0214046-2A BR0214046A BR0214046A BR 0214046 A BR0214046 A BR 0214046A BR 0214046 A BR0214046 A BR 0214046A BR 0214046 A BR0214046 A BR 0214046A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- psychopharmaceuticals
- pyrazole derivatives
- manufacture
- movement disorders
- Prior art date
Links
- 150000003217 pyrazoles Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 3
- 208000027776 Extrapyramidal disease Diseases 0.000 abstract 2
- 208000016285 Movement disease Diseases 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 229940035678 anti-parkinson drug Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01126531 | 2001-11-14 | ||
| PCT/EP2002/011464 WO2003042208A1 (en) | 2001-11-14 | 2002-10-14 | Pyrazole derivatives as psychopharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0214046A true BR0214046A (pt) | 2004-10-13 |
Family
ID=8179188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0214046-2A BR0214046A (pt) | 2001-11-14 | 2002-10-14 | Derivados de pirazol como substâncias psicofarmacêuticas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050026927A1 (https=) |
| EP (1) | EP1444229A1 (https=) |
| JP (1) | JP2005511625A (https=) |
| KR (1) | KR20050036882A (https=) |
| CN (1) | CN1585768A (https=) |
| BR (1) | BR0214046A (https=) |
| CA (1) | CA2467081A1 (https=) |
| HU (1) | HUP0402124A2 (https=) |
| MX (1) | MXPA04004443A (https=) |
| PL (1) | PL369674A1 (https=) |
| WO (1) | WO2003042208A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0320320D0 (en) * | 2003-08-29 | 2003-10-01 | Glaxo Group Ltd | Novel compounds |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
| WO2006002284A1 (en) * | 2004-06-22 | 2006-01-05 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| WO2012074853A1 (en) | 2010-11-22 | 2012-06-07 | The Regents Of The University Of California | Organic small molecule semiconducting chromophores for use in organic electronic devices |
| ES2707886T3 (es) | 2012-02-14 | 2019-04-05 | Next Energy Tech Inc | Dispositivos electrónicos que usan compuestos semiconductores orgánicos de molécula pequeña |
| US9865821B2 (en) * | 2012-02-17 | 2018-01-09 | Next Energy Technologies, Inc. | Organic semiconducting compounds for use in organic electronic devices |
| CN104768949A (zh) * | 2012-08-24 | 2015-07-08 | 特温蒂斯公司 | 苯并呋咱抗淀粉样蛋白化合物和方法 |
| CN104854175A (zh) * | 2012-12-18 | 2015-08-19 | 默克专利股份有限公司 | 包含噻二唑基的聚合物、这种聚合物的制备和它在有机电子器件中的用途 |
| JP6663361B2 (ja) * | 2014-02-27 | 2020-03-11 | トレヴェンティス コーポレーション | ベンゾフラザンを含有する抗アミロイド化合物 |
| CA3005766A1 (en) | 2015-12-17 | 2017-06-22 | Merck Patent Gmbh | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders |
| JP7125385B2 (ja) | 2016-08-08 | 2022-08-24 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｔｌｒ７／８アンタゴニストおよびそれらの使用 |
| WO2024124439A1 (zh) * | 2022-12-14 | 2024-06-20 | 苏州大学 | 一种抗菌抗肿瘤增效剂及其合成方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6517196A (en) * | 1995-07-13 | 1997-02-10 | Knoll Aktiengesellschaft | Piperazine derivatives as therapeutic agents |
| DE19602505A1 (de) * | 1996-01-25 | 1997-07-31 | Merck Patent Gmbh | 1-(Pyrazol-4-Indol-3-yl)-Piperidine |
-
2002
- 2002-10-14 PL PL02369674A patent/PL369674A1/xx unknown
- 2002-10-14 CA CA002467081A patent/CA2467081A1/en not_active Abandoned
- 2002-10-14 WO PCT/EP2002/011464 patent/WO2003042208A1/en not_active Ceased
- 2002-10-14 MX MXPA04004443A patent/MXPA04004443A/es unknown
- 2002-10-14 CN CNA02822566XA patent/CN1585768A/zh active Pending
- 2002-10-14 HU HU0402124A patent/HUP0402124A2/hu unknown
- 2002-10-14 BR BR0214046-2A patent/BR0214046A/pt not_active Application Discontinuation
- 2002-10-14 KR KR1020047006057A patent/KR20050036882A/ko not_active Withdrawn
- 2002-10-14 EP EP02785208A patent/EP1444229A1/en not_active Withdrawn
- 2002-10-14 US US10/495,456 patent/US20050026927A1/en not_active Abandoned
- 2002-10-14 JP JP2003544044A patent/JP2005511625A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1585768A (zh) | 2005-02-23 |
| PL369674A1 (en) | 2005-05-02 |
| KR20050036882A (ko) | 2005-04-20 |
| MXPA04004443A (es) | 2004-08-11 |
| HUP0402124A2 (hu) | 2005-02-28 |
| EP1444229A1 (en) | 2004-08-11 |
| CA2467081A1 (en) | 2003-05-22 |
| JP2005511625A (ja) | 2005-04-28 |
| WO2003042208A1 (en) | 2003-05-22 |
| US20050026927A1 (en) | 2005-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0510770A (pt) | derivados de fluorglicosìdeos de pirazóis, medicamentos contendo esses compostos e seu uso | |
| BRPI0407897A (pt) | derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios | |
| BR0207715A (pt) | Compostos, composições farmacêuticas, e uso de um ou mais compostos | |
| BR0207910A (pt) | HidantÈnios e sua utilização no tratamento do diabetes | |
| EA200900733A1 (ru) | ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-c]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ | |
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| BR0108611A (pt) | Moduladores de receptor de adenosina | |
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| MEP36608A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
| BR0214757A (pt) | Formulações farmacêuticas de derivados de platina | |
| DE60220887D1 (de) | Agonisten von beta-adrenorezeptoren | |
| BR0314635A (pt) | Derivados de piridina como moduladores de receptores de cb2 | |
| UA83862C2 (ru) | Производные тиазола как модуляторы рецепторов канабиноидов | |
| BR0313676A (pt) | Derivados de pirimidina e uso destes como moduladores cb2 | |
| BR0214046A (pt) | Derivados de pirazol como substâncias psicofarmacêuticas | |
| BRPI0517458A (pt) | derivados da xantina com atividade para o receptor hm74a | |
| BR0211995A (pt) | Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação | |
| BR0212031A (pt) | Preparados de combinação de derivados de 1,1-dióxido de 1-4-benzotiepina com outras substâncias ativas e seu emprego | |
| BR9914266A (pt) | Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego | |
| BR0206549A (pt) | Uso de flumazenil na produção de uma droga para o tratamento de dependência de álcool | |
| ATE173627T1 (de) | Medizinische zusammensetzung | |
| BRPI0413110A (pt) | derivados de indo-5-il sulfonamida, sua preparação e uso de 5-ht-6 como moduladores | |
| BR0210473A (pt) | Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |